Literature DB >> 8806107

GRP receptors are present in non small cell lung cancer cells.

T W Moody1, F Zia, R Venugopal, M Fagarasan, H Oie, V Hu.   

Abstract

Previously, GRP receptors were characterized in small cell lung cancer cells and here non-small cell lung cancer (NSCLC) cells were investigated: (125I-Tyr4) bombesin (BN) or 125I-GRP bound with high affinity to NCI-H720 (lung carcinoid) and NCI-H1299 (large cell carcinoma) cells. Binding was specific, time dependent, and saturable. Specific (125I-Tyr4)BN binding to NCI-H1299 cells was inhibited with high affinity by GRP, BN, GRP14-27, (D-Phe6)BN6-13methyl ester, moderate affinity by NMB, and low affinity by GRP1-16. BN (10 nM) transiently elevated cytosolic calcium in a dose dependent manner. BN caused translocation of protein kinase C from the cytosol to the membrane and the translocation caused by BN was reversed by (D-Phe6)BN6-13methylester. BN stimulated arachidonic acid release and the increase caused by BN was reversed by (D-Phe6)BN6-13methylester. Using a clonogenic assay, BN stimulated the growth of NCI-H720 cells, and the number of colonies was reduced using (D-Phe6)BN6-13methylester. These data suggest that GRP receptors that are present in lung carcinoid and NSCLC cells may regulate proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806107     DOI: 10.1002/jcb.240630520

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN: 0733-1959


  8 in total

1.  Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a "biased agonist" mechanism.

Authors:  Daniel Chan; Lajos Gera; John Stewart; Barbara Helfrich; Marileila Verella-Garcia; Gary Johnson; Anna Baron; Jie Yang; Theodore Puck; Paul Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

3.  68Ga-Labeled [Leu13ψThz14]Bombesin(7-14) Derivatives: Promising GRPR-Targeting PET Tracers with Low Pancreas Uptake.

Authors:  Lei Wang; Zhengxing Zhang; Helen Merkens; Jutta Zeisler; Chengcheng Zhang; Aron Roxin; Ruiyan Tan; François Bénard; Kuo-Shyan Lin
Journal:  Molecules       Date:  2022-06-11       Impact factor: 4.927

Review 4.  Targeting GRPR in urological cancers--from basic research to clinical application.

Authors:  Rosalba Mansi; Achim Fleischmann; Helmut R Mäcke; Jean C Reubi
Journal:  Nat Rev Urol       Date:  2013-03-19       Impact factor: 14.432

Review 5.  Improved biochemical strategies for targeted delivery of taxoids.

Authors:  Thota Ganesh
Journal:  Bioorg Med Chem       Date:  2007-03-18       Impact factor: 3.641

Review 6.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

7.  A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells.

Authors:  H C Weber; J Walters; J Leyton; M Casibang; S Purdom; R T Jensen; D H Coy; C Ellis; G Clark; T W Moody
Journal:  Eur J Pharmacol       Date:  2001-01-19       Impact factor: 4.432

8.  Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.

Authors:  Hao Zuo; Grace P W Chan; Jing Zhu; Wendy W S Yeung; Anthony S L Chan; Hermann Ammer; Yung H Wong
Journal:  Cell Commun Signal       Date:  2013-08-15       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.